Dr. Peter Laurence, DMD ,
-
How Heavy Advertising Can Mislead Seniors About Medicare Advantage Plans
Heavy advertising for Medicare Advantage plans often features celebrity endorsements and promises of enticing benefits, but such marketing can sometimes mislead seniors about the true nature of these plans. According to sources like Medicare.gov and the Kaiser Family Foundation, many Advantage plans may include hidden drawbacks such as limited provider networks, complex prior authorization requirements, and unexpected out-of-pocket costs for certain services. This article helps readers by encouraging them to look beyond advertising claims, urging a careful comparison of plan details, coverage, and costs. By highlighting potential pitfalls and providing authoritative guidance, the article empowers seniors to make more informed choices about their health insurance, ensuring they select a plan that truly meets their needs.
-
Aurora Sheboygan Prices – BRIVARACETAM 50 MG/5ML IV SOLN is $188.55
At Aurora Medical Center Sheboygan, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10002800, regarding BRIVARACETAM 50 MG/5ML IV SOLN, which is classified under revenue code 250 and associated with CPT code C9399, the designated fee stands at $188.55. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
Aurora Bay Area Prices – PLEURAL DRAINAGE W/O IMAGING is $2,130.00
At Aurora Bay Area, we prioritize providing our patients with comprehensive financial information upfront. For Charge Code 10004802, regarding PLEURAL DRAINAGE W/O IMAGING, which is classified under revenue code 360 and associated with CPT code 32556, the designated fee stands at $2,130.00. Our aim through the CompareMedCosts program is to furnish you with all the details you need to make informed healthcare decisions, offering clarity and transparency around the costs associated with your care.
-
CMS proposes faster prior-authorization rules for drugs
CMS has proposed new electronic prior-authorization rules for drugs that could shorten some approval waits, but the change is not final. The plan would still need public comments, a final rule, and plan-by-plan implementation before patients see any effect.